|1.||Kia, Yalda: 1 article (01/2015)|
|2.||Ali, Hapipah Mohd: 1 article (01/2015)|
|3.||Karimian, Hamed: 1 article (01/2015)|
|4.||Murugaiyah, Vikneswaran: 1 article (01/2015)|
|5.||Fadaeinasab, Mehran: 1 article (01/2015)|
|6.||Basiri, Alireza: 1 article (01/2015)|
|1.||Hypertension (High Blood Pressure)
08/15/1958 - "[Rescinnamine in the treatment of benign essential arterial hypertension; preliminary trial]."
11/15/1970 - "[Value of a thiazic-antialdosterone-rescinnamine association in the treatment of arterial hypertension (42 cases)]."
01/31/1961 - "[Action of rescinnamine, Rauwolfia serpentina alkdloid, on renal hemodynamics in patients with arterial hypertension]."
12/24/1960 - "Rescinnamine in treatment of hypertension in hospital clinic and in general practice."
05/01/1956 - "The response to rescinnamine administered parenterally and orally for the treatment of hypertension."
|2.||Hypotension (Low Blood Pressure)
|3.||Ganglion Cysts (Ganglion)
|4.||Brain Diseases (Brain Disorder)
01/01/2015 - "Plants from the Apocynaceae family have been traditionally used in the treatment of age-related brain disorders Methods and Results: Two new indole alkaloids, rauvolfine C (1) and 3-methyl-10,11-dimethoxy-6-methoxycarbonyl-β-carboline (2), along with five known, macusine B (3), vinorine (4), undulifoline (5), isoresrpiline (6) and rescinnamine (7) were isolated from the bark of Rauvolfia reflexa. "